Author
@Merck Merck
Official Merck corporate account broadcasting its own pipeline, regulatory, and earnings milestones
Publish first-party corporate communications — clinical tria
trader score
·
hit rate
·
mean α
·
signals 14d
2
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Not yet in the scored-bets universe (fewer than 20 scoreable calls). Their last-14d mentions, direction-adjusted, have moved +1.0% since posting (mean over 2 mentions with price data).
Recent signals2receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-10-13 | MRK | @Merck | +0.15 | Merck announces new oncology data presentations, including three pivotal Phase 3 trials. | +2.3% | tweet ↗ |
| 2026-10-10 | MRK | @Merck | +0.10 | Merck is presenting Phase 2b/3 investigational DME trial data at AAO2026. | -0.2% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.